Pay in 4 interest-free payments of $7.48 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
N.PippengerC
Tesamorelin (Egrifta) has been FDA-approved since November 2010 for the reduction of excess abdominal fat in HIV-positive adults with lipodystrophy
Pre-Defined Profiles: Select from preset peptides profiles that help beginners start faster and standardise common research workflows
Research indicates dosage and timing determine the impact
Analytical testing confirms Tesamorelin purity of 99.7 % and Ipamorelin purity above 99.8 % , with assay content verified at 10.90 mg and 3.57 mg respectively
Discuss your medical history, current medications, and treatment goals to determine the most appropriate option for your specific situation
US$ 21.52
US$ 21.10
.png.jpg)
US$ 28.93
US$ 28.44
